{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:18:22Z","timestamp":1786990702028,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN2010H834LS"],"award-info":[{"award-number":["PRIN2010H834LS"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ijpharm.2016.07.043","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T11:12:55Z","timestamp":1469185975000},"page":"516-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Mechanisms of imiquimod skin penetration"],"prefix":"10.1016","volume":"511","author":[{"given":"Isabella","family":"Tel\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pescina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Padula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7601-7894","authenticated-orcid":false,"given":"Patrizia","family":"Santi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6955-0957","authenticated-orcid":false,"given":"Sara","family":"Nicoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.07.043_bib0005","series-title":"ACD\/Percepta, Version 2015. Pack 2, Toronto, On, Canada","author":"Advanced Chemistry Development Inc","year":"2015"},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0378-5173(95)00141-5","article-title":"Fourier transform raman spectroscopy of interactions between the penetration enhancer dimethyl sulfoxide and human stratum corneum","volume":"125","author":"Anigbogu","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1470-2045(13)70143-8","article-title":"Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial","volume":"14","author":"Arits","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0168-3659(87)90066-6","article-title":"Mode of action of penetration enhancers in human skin","volume":"6","author":"Barry","year":"1987","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0378-5173(94)00267-9","article-title":"Influence of propylene glycol as cosolvent on mechanisms of drug transport from hydrogels","volume":"116","author":"Bendas","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0030","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/jps.23627","article-title":"Adapalene microemulsion for transfollicular drug delivery","volume":"102","author":"Bhatia","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10837459908984222","article-title":"Development of a topically active imiquimod formulation","volume":"4","author":"Chollet","year":"1999","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0040","first-page":"567","article-title":"Measuring the effects of topical moisturizers on changes in stratum corneum thickness, water gradients and hydration in vivo","volume":"159","author":"Crowther","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0045","first-page":"1300","article-title":"Imiquimod: a review of off-label clinical applications","volume":"10","author":"David","year":"2011","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0050","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1524-4725.2012.02362.x","article-title":"Melanoma in situ treated successfully using imiquimod after nonclearance with surgery: review of the literature","volume":"38","author":"Ellis","year":"2012","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0055","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/eji.201344094","article-title":"Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+ T-cell cross-priming","volume":"44","author":"Fehres","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0060","article-title":"Penetration mechanism of dimethyl sulfoxide in human and pig ear skin: an ATR\u2fffFTIR and near-FT Raman spectroscopic in vivo and in vitro study","volume":"22","author":"Greve","year":"2008","journal-title":"J. Spectrosc."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0065","series-title":"Hansen Solubility Parameters: A User's Handbook","author":"Hansen","year":"2007"},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejps.2015.06.013","article-title":"Topical therapies for skin cancer and actinic keratosis","volume":"77","author":"Haque","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0075","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1021\/mp100068s","article-title":"Uptake of microemulsion components into the stratum corneum and their molecular effects on skin barrier function","volume":"7","author":"Hathout","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/bjd.13460","article-title":"Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal","volume":"172","author":"Lecluse","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/pharmaceutics6010052","article-title":"Overcoming the cutaneous barrier with microemulsions","volume":"6","author":"Lopes","year":"2014","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejpb.2014.04.019","article-title":"Simultaneous analysis of skin penetration of surfactant and active drug from fluorosurfactant-based microemulsions","volume":"88","author":"Mahrhauser","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0095","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijpharm.2015.05.056","article-title":"Investigation of microemulsion microstructure and its impact on skin delivery of flufenamic acid","volume":"490","author":"Mahrhauser","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0192-0561(98)00068-X","article-title":"Imiquimod applied topically: a novel immune response modifier and new class of drug","volume":"21","author":"Miller","year":"1999","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2015.05.022","article-title":"A quantitative systematic review of the efficacy of imiquimod monotherapy for lentigo maligna and an analysis of factors that affect tumor clearance","volume":"73","author":"Mora","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0939-6411(01)00166-7","article-title":"Passive skin penetration enhancement and its quantification in vitro","volume":"52","author":"Moser","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0115","unstructured":"National Institutes of Health, 2016. ClinicalTrials.gov, p. http:\/\/clinicaltrials.gov\/."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0120","unstructured":"OECD, 2011. ENV\/JM\/MONO(2011)36 Guidance notes on dermal absorption \u2fff Series on testing and assessment n. 156 Paris."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0125","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1468-2494.2012.00753.x","article-title":"The role of vehicle interactions on permeation of an active through model membranes and human skin","volume":"34","author":"Oliveira","year":"2012","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0378-5173(96)04768-0","article-title":"Evaluation of drug penetration into human skin ex vivo using branched fatty acids and propylene glycol","volume":"145","author":"Schneider","year":"1996","journal-title":"Int. J. Pharm."},{"issue":"Suppl. 2","key":"10.1016\/j.ijpharm.2016.07.043_bib0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2133.2007.08265.x","article-title":"Imiquimod: mode of action","volume":"157","author":"Schon","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0140","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/djg016","article-title":"Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod","volume":"95","author":"Schon","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0145","doi-asserted-by":"crossref","first-page":"e102664","DOI":"10.1371\/journal.pone.0102664","article-title":"Efficacy of imiquimod-based transcutaneous immunization using a nano-dispersed emulsion gel formulation","volume":"9","author":"Stein","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0150","first-page":"319","article-title":"Using solubility parameters in cosmetics formulation","volume":"36","author":"Vaughan","year":"1985","journal-title":"J. Soc. Cosmet. Chem."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0155","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/ncomms2566","article-title":"Aldara activates TLR7-independent immune defence","volume":"4","author":"Walter","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpharm.2016.07.043_bib0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.09.014","article-title":"Investigation of microemulsion microstructures and their relationship to transdermal permeation of model drugs: ketoprofen, lidocaine, and caffeine","volume":"421","author":"Zhang","year":"2011","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316306937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316306937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T22:20:25Z","timestamp":1656627625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316306937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0378517316306937"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.043","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of imiquimod skin penetration","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}